[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Glaucoma Drainage Devices - Medical Devices Pipeline Assessment, 2020

August 2020 | 40 pages | ID: GB9B0C10C854EN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Glaucoma Drainage Devices - Medical Devices Pipeline Assessment, 2020

SUMMARY

GlobalData's Medical Devices sector report, “Glaucoma Drainage Devices%li%Medical Devices Pipeline Assessment, 2020 ' provides comprehensive information about the Glaucoma Drainage Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Glaucoma drainage device or implant is a small plastic device that is surgically attached to the eye's surface to improve or shunt the flow of aqueous drainage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Glaucoma Drainage Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Glaucoma Drainage Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Glaucoma Drainage Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Glaucoma Drainage Devices Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Glaucoma Drainage Devices - Pipeline Products by Stage of Development
3.2 Glaucoma Drainage Devices - Pipeline Products by Territory
3.3 Glaucoma Drainage Devices - Pipeline Products by Regulatory Path
3.4 Glaucoma Drainage Devices - Pipeline Products by Estimated Approval Date
3.5 Glaucoma Drainage Devices - Ongoing Clinical Trials

4 GLAUCOMA DRAINAGE DEVICES - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Glaucoma Drainage Devices Companies - Pipeline Products by Stage of Development
4.2 Glaucoma Drainage Devices - Pipeline Products by Stage of Development

5 GLAUCOMA DRAINAGE DEVICES COMPANIES AND PRODUCT OVERVIEW

5.1 Alievio Inc Company Overview
5.2 Avisi Technologies LLC Company Overview
5.3 Geuder AG Company Overview
5.4 InnFocus Inc Company Overview
5.5 iVeena Delivery Systems Inc Company Overview
5.6 Medtronic Plc Company Overview
5.7 Meir Medical Center Company Overview
5.8 Merz Anteis SA Company Overview
5.9 MicroOptx, Inc. Company Overview
5.10 OPKO Health Inc Company Overview
5.11 Purdue University Company Overview
5.12 Sheba Medical Center Company Overview
5.13 Tel Aviv University Company Overview
5.14 University of Colorado Company Overview
5.15 University of Michigan Company Overview

6 GLAUCOMA DRAINAGE DEVICES- RECENT DEVELOPMENTS

6.1 May 13, 2020: OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network enter into strategic laboratory collaboration to deliver operational and diagnostic services
6.2 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results
6.3 Aug 30, 2019: Santen announces topline pivotal data for DE-128 (MicroShunt) demonstrating reductions in intraocular pressure and medication use in patients with mild, moderate and severe primary open-angle glaucoma

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Glaucoma Drainage Devices - Pipeline Products by Stage of Development
Table 2: Glaucoma Drainage Devices - Pipeline Products by Territory
Table 3: Glaucoma Drainage Devices - Pipeline Products by Regulatory Path
Table 4: Glaucoma Drainage Devices - Pipeline Products by Estimated Approval Date
Table 5: Glaucoma Drainage Devices - Ongoing Clinical Trials
Table 6: Glaucoma Drainage Devices Companies - Pipeline Products by Stage of Development
Table 7: Glaucoma Drainage Devices - Pipeline Products by Stage of Development
Table 8: Alievio Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Camras Shunt - Product Status
Table 10: Camras Shunt - Product Description
Table 11: Avisi Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 12: VisiPlate - Product Status
Table 13: VisiPlate - Product Description
Table 14: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Microsystem Implant - Product Status
Table 16: Microsystem Implant - Product Description
Table 17: InnFocus Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: PreserFlo MicroShunt - Product Status
Table 19: PreserFlo MicroShunt - Product Description
Table 20: InnFocus Inc - Ongoing Clinical Trials Overview
Table 21: PreserFlo MicroShunt - A Prospective, Concurrent Controlled, Open-label, Multicenter Clinical Study to Assess the Long-term Safety of the PRESERFLO MicroShunt in Subjects with Primary Open-angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study
Table 22: PreserFlo MicroShunt - Intraocular Pressure after Preserflo /Innfocus Microshunt Vs Trabeculectomy: A Prospective, Randomized Control-trial (PAINT-Study)
Table 23: PreserFlo MicroShunt - SIGHT study: Cost-effectiveness of InnFocus Microshunt (IMS) Implantation Versus Standard Trabeculectomy (TE)
Table 24: iVeena Delivery Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: IVMED-70 - Product Status
Table 26: IVMED-70 - Product Description
Table 27: Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: CellPlant - Product Status
Table 29: CellPlant - Product Description
Table 30: Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Glaucoma Drainage Device - Product Status
Table 32: Glaucoma Drainage Device - Product Description
Table 33: Merz Anteis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Drainage Viscoelastic Injectable Implant - Product Status
Table 35: Drainage Viscoelastic Injectable Implant - Product Description
Table 36: MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Brown Glaucoma Implant (BGI) - Product Status
Table 38: Brown Glaucoma Implant (BGI) - Product Description
Table 39: MicroOptx, Inc. - Ongoing Clinical Trials Overview
Table 40: Brown Glaucoma Implant (BGI) - A Prospective, Multicenter Study to Evaluate the Safety and Effectiveness of Beacon Aqueous Microshunt for Refractory Glaucoma: The Beacon Study

LIST OF FIGURES

Figure 1: Glaucoma Drainage Devices - Pipeline Products by Stage of Development
Figure 2: Glaucoma Drainage Devices - Pipeline Products by Territory
Figure 3: Glaucoma Drainage Devices - Pipeline Products by Regulatory Path
Figure 4: Glaucoma Drainage Devices - Pipeline Products by Estimated Approval Date
Figure 5: Glaucoma Drainage Devices - Ongoing Clinical Trials

COMPANIES MENTIONED

Alievio Inc
Avisi Technologies LLC
Geuder AG
InnFocus Inc
iVeena Delivery Systems Inc
Medtronic Plc
Meir Medical Center
Merz Anteis SA
MicroOptx, Inc.
OPKO Health Inc
Purdue University
Sheba Medical Center
Tel Aviv University
University of Colorado
University of Michigan


More Publications